knowledge -WSS

knowledge

author：entertainment 2025-10-02 20:52:30 - browse：7

Illustration fo a pink arrow pointing downward. -- biotech coverage from STAT — Adobe

SAN DIEGO — Ventyx Biosciences reported on Monday that it was ending development of an experimental drug for treating plaque psoriasis though it proved safe and moderately effective in a mid-stage trial. Within hours, the company’s stock tanked by more than 80%.

That’s because the company announced that the small molecule, VTX958, had not met the biotech’s internal goals to advance to the next phase of clinical development. Ventyx said it would end work on the drug, which targets the signaling molecule TYK2, as a treatment for psoriasis and psoriatic arthritis.

Shares in Ventyx plummeted from $14.09 at market close to as little as $2.72 during after-hours trading. In the process, the company’s market value dropped from $830 million to around $160 million. Ventyx is now trading below its cash balance, which was $300 million as of the end of September.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

entertainment

WSS

Doctors in states that ban abortion can still help patients

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Snowpack in the West is melting rapidly. Where will all that extra water go?

Doctors in states that ban abortion can still help patients

Body of missing toddler recovered in Delaware River days after flood: Police

Why an extreme heat and wildfire smoke combination can be so dangerous

focus

knowledge

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

In age of alternative facts, a scholarly course on calling out crap

AbbVie dramatically boosts its spending on lobbying

DIEP, the 'gold standard' of breast reconstruction, is under threat

Europe is fastest

Alkermes shareholders re

'Weather

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A double vaccine crisis is endangering millions of children

hotspot

Body of missing toddler recovered in Delaware River days after flood: Police

Doctors in states that ban abortion can still help patients

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Many immigrants are left out of maternal health programs

Europe is fastest

knowledge

explore

entertainment

leisure time